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Summary
Objective: To estimate survival probabilities and identify risk factors for death of tuberculosis (TB) patients during
treatment period.
Methods:  TB patients registered during May 1999 to December 2004 from a rural TB unit (TU) with a population of
580 000 in Tiruvallur district, South India, formed study population. Life table and Cox’s regression methods were used.
Results:  Of the 3818 TB patients who were initiated on treatment, 96, 94 and 97% of category – I, II and III
respectively, were surviving after completion of treatment.  Higher death rates were independently associated with
patient’s age (45 years), previous history of treatment, alcoholism and initial body weight (<35 kgs).
Conclusion:  The survival probability was found to be similar in all patients irrespective of categorization.  Necessary
actions need to be initiated in the programme to improve body weight and abstain from alcoholism.
Key words: Tuberculosis, Death, Cox proportional hazard model, Life table, Risk factors.
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INTRODUCTION
Tuberculosis (TB) is an infectious disease.
It continues to be a leading cause of death1.  Globally,
there are almost nine million new cases of TB each
year, two million of which results in death.  More
than one-third of these cases and deaths are in India
and China2.  TB incidence in India accounts for one
fifth of the global incidence3.  In India, every year,
almost 1.8 million new cases occur, of which almost
half are infectious and 370, 000 die3.  Patients with
infectious pulmonary TB disease can infect 10-15
persons in a year3.  Directly Observed Treatment,
Short-course (DOTS), strategy in TB control has
considerably improved the quality of diagnosis and
treatment outcome globally. In India, DOTS was
implemented since 1993 for effective management
of TB treatment.  The goal of TB control programme
is to decrease mortality and morbidity due to TB
and cut transmission of TB in the community.  For
the individual patients and the DOT providers, the
treatment outcome is of more interest in particular
the probability of surviving the disease.  The duration
of the treatment is also important in deciding the
survival of the patients.   In this study, we attempted
to estimate survival probabilities and identify risk
factors for death of TB patients during treatment
period.
METHODS
It is a retrospective study from a rural TB
unit (TU) with a population of 580000 in Tiruvallur
district, South India. The study area includes 209
villages and nine urban clusters scattered across
approximately 200 sq. kms.  The DOTS strategy
was implemented in this area since May 19994. There
are 17 governmental health facilities (HFs)
participating in the programme and of these, seven
offer diagnostic facilities for sputum examination.
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All the patients diagnosed with TB at one of these
Health Facilities (HFs) are given DOT in accordance
with RNTCP policies5.  Every dose of treatment is
to be directly observed during intensive phase (IP)
and at least first of the three doses is to be directly
observed during continuation phase.
During May 1999 – December 2004,
5366 TB patients were registered for treatment
under DOTS at the HFs in this area.  The data on
socio- economic demographic profile was
collected within a week of starting the treatment
and the treatment profile at the end of the IP.
Trained field staff interviewed 3818 (71%)
patients at their residence and collected
information on socio-economic demographic
profile, body weight at initiation of treatment,
history of previous treatment, smoking and
drinking habits, whether they took treatment under
supervision and type of DOT provider using a
semi-structured questionnaire.  Category and
treatment outcome were collected from TB
register maintained by TU.  Category I is defined
as all new cases that are sputum smear positive
or seriously ill patients with smear negative or
extra-pulmonary disease.  Category II patients are
cases who have had previous anti-tuberculosis
treatment.  Category III regimen is prescribed to
new patients who are smear negative or extra-
pulmonary TB and are not seriously ill.  The anti-
tuberculosis regimens used for Category I, II and
III patients were 2H3R3Z3 E3/4H3R3, 2H3R3Z3 E3S3 /
1H3R3Z3 E3/5H 3R3E3, and 2H3R3Z3 /4H3R3
respectively  (H = isoniazid; R = rifampicin; Z =
pyrazinamide; E = ethambutol; S = streptomycin.
Numbers before the letters indicate the duration
of the treatment phase in months and numbers in
subscript indicate the number of times the drug
is given each week).  Treatment for category I
and II patients was extended by another month if
the sputum smear remained positive at the end of
IP.   Standard international definitions were
followed to classify TB patients according to
outcome5.
Data were scrutinized and entered twice in
order to ensure accuracy, corrected for discrepancy
and missing information.  Life table method was
Table 1: Characteristics of TB patients
registered under DOTS in a rural
district, South India.
*The number of patients is less than 3,818 due to the non-
availability  at the time of interview within a week after
treatment began.
used to estimate survival and hazard functions of
survival times of TB patients for three categories
separately.   Using this analysis survival curves were
constructed for the three categories of patients.
Wilcoxon (Gehan) test was used to compare survival
times of TB patients between categories. The Life
Factors Total (%)
n = 3818
Sex
Female 1048 (27)
Male 2770 (73)
Age (Years)
<45 2013 (53)
>45 1805 (47)
Education
Illiterate 1626 (43)
Literate 2192 (57)
Occupation
Unemployed   935 (24)
Employed 2883 (76)
Weight (Kg)*
<35   495 (13)
>35 3054 (80)
Smoking*
No 2230 (58)
Yes 1586 (42)
Alcoholism*
No 2619 (69)
Yes 1197 (31)
Category
I 1944 (51)
II   449 (12)
III 1425 (37)
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Table 2: Estimates of life survival and hazard functions for Categories I, II and III
 Category I Category II Category III 
Interval nj cj dj S(t) h(t) nj cj dj S(t) h(t) nj cj dj S(t) h(t) 
   0 1944 20 4 .9979 .0021 449 18 0 1.0000 .0000 1425 22 1 .9993 .0007 
   1 1920 48 8 .9937 .0042 431 26 4 0.9904 .0096 1402 43 3 .9971 .0022 
   2 1864 38 2 .9926 .0011 401 26 6 0.9751 .0156 1356 29 4 .9941 .0030 
   3 1824 35 14 .9850 .0078 369 24 1 0.9724 .0028 1323 22 5 .9904 .0038 
   4 1775 50 13 .9776 .0075 344 22 0 0.9724 .0000 1296 25 10 .9826 .0078 
   5 1712 157 10 .9716 .0061 322 19 0 0.9724 .0000 1261 153 6 .9777 .0051 
   6 1545 809 8 .9648 .0070 303 20 5 0.9558 .0172 1102 757 3 .9736 .0042 
   7 728 339 1 .9631 .0018 278 72 3 0.9439 .0125 342 196 2 .9656 .0082 
   8+ 388 378 10 .9147 *** 203 198 5 0.8986 *** 144 142 2 .9392 *** 
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Figure: Survival curves of TB patients under three categories
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table estimate of survival function S(t) and hazard
function h(t) are given by 
))(2/()( / jjj
j
dn
d
th
τ−
=
Where nj = Number of individual who are alive and
therefore at risk of death, at the start of j’th interval
dj = Number of deaths in the j’th time interval, j
=1,2,…,m.
cj = Number of censored survival time in this interval
nj
/ 
= average number of individuals who are at risk
during this interval = nj –cj /2
   = the length of j’th time interval.
Cox’s proportional hazards model was performed
to identify risk factors for death during treatment
period using backward stepwise procedure by SPSS
version 10.0.  Adjusted hazard ratio and 95%
confidence interval (CI) were estimated for the risk
factors. The level of statistical significance was
defined as p<0.05.
RESULTS
Among 3818 TB patients registered under
DOTS programme, 2770 (73%) were males, 1805
(47%) were 45 years and above, 3054 (80%) had
weight more than 34 kgs, 1626 (43%) were illiterate
and 935 (24%) unemployed.  The life style indicators
for the patients were:  1586 (42%) smokers and
1197 (31%) alcoholics.  Of the 3818 patients treated,
1944 (51%) were under category I, 449 (12%) under
category II and 1425 (37%) under category III
(Table 1).  For these patients, the treatment outcomes
were as follows: 1538 (40.3%) (Category I- 70.2%
and Category II- 38.8%) were cured, 1468 (38.4%)
(Category I- 10.0%, Category II-9.8% and Category
III- 86.2%) had completed treatment, 535 (14%)
(Category I- 11.5%, Category II- 38.5% and
Category III- 9.8%) defaulted, 130 (3.4%) (Category
I- 3.6%, Category II- 5.3% and Category III- 2.5%)
expired, 144 (3.8%) (Category I- 4.7%, Category
II- 7.6%  and Category III- 1.3%) failed treatment
and 3 (0.1%) (Category I- 0.1%, and Category III-
0.1%) were transferred out.
Using Life Table estimate method, survival
probabilities of the patients were 99.4%, 99.0% and
99.7% for category I, II and III respectively after
the first month of treatment. The corresponding
survival probabilities were 98.5%, 97.2% and 99.0%
respectively after the three months and 96.3%,
94.4% and 96.6% respectively after seven months
of treatment (Table 2).  Using Wilcoxon (Gehan)
test, there was no significant difference between
the survival times of TB patients among the three
categories (p = 0.1).  The survival probability against
time in months for category I, II and III  is separately
shown (Fig).  The gap between the three curves
distinguishes the difference between survival
distributions, where the curve for category II
decreases compared to that of category III and I.
From this curve, it is understood that the survival
probabilities of category III patients is more than
category I patients during treatment period but
survival probabilities of category II is less than
category III and I.
Of the 3818 patients, 305 cases with
missing values were excluded for multivariate
analysis (Cox proportional hazard model). Of 3513
patients, 109 (3.1%) deaths occurred during
treatment period. Duration in months from diagnosis
of TB to end of the treatment period and treatment
outcomes was measured for 3404 (96.9%) those
who were alive at the end of treatment.  The variables
considered for the model were sex, age, category,
education, occupation, body weight at initiation of
treatment (<35 kg), history of previous anti TB
treatment, smoking and drinking habits, type of DOT
providers, whether patient took treatment under
supervision in intensive phase and continuation
phase. Age (≥45 years), previous history of
treatment, alcoholism and body weight at initiation
of treatment (<35 kg) were found to be risk factors
for death during treatment period.  The
corresponding adjusted hazard ratios were 2.345
(95% C.I.: 1.557, 3.533), 1.615 (95% C.I.: 1.102,
2.368), 2.015 (95% C.I.: 1.357, 2.992) and 3.709
(95% C.I.: 2.434, 5.652) respectively (Table 3).  The
other factors namely; sex, category, education,
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Table 3: Results of Cox’s proportional hazard model of risk factors for death during treatment period.
occupation, smoking, type of DOT providers and
supervision under IP were not found to be significant
for risk of death during treatment period.
DISCUSSION
Our study findings show that 94-97% of
patients were surviving at the end of seven months
of anti-tuberculosis treatment, irrespective of
categories.  A multivariate analysis of the study found
that age (≥45), body weight at initiation of treatment
(<35 kgs), previous history of treatment and
alcoholism were risk factors associated with death
during anti-tuberculosis treatment period.  A study6
conducted by our centre in Chennai city showed
that 91% patients treated for TB survived the entire
follow-up period of 600 days from the date of start
of treatment and 9% patients died during the follow-
up period.  The risk factors identified for TB
mortality were young age, male sex, smear postivity,
treatment default, treatment failure and the
combination of smoking and alcoholism. In the
study, survivors were followed up after completion
of treatment for a minimum period of 600 days.
But our study was confined to the treatment duration
and this could be the reason for age (≥45) identified
as risk factor.  In a study from Netherlands7,
survival probabilities for tuberculosis patients were
estimated as 95% after six months of treatment and
6% died within one year while on treatment.  The
study identified the following risk factors for
mortality of tuberculosis patients: male sex, age (>65
years), presence of malignancy, human immune-
deficiency virus (HIV) infection, addiction to alcohol
or drugs, localization of tuberculosis (pulmonary and
extra pulmonary tuberculosis) and type of medical
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Factors No. Registered No. of 
Death 
p Adjusted hazard ratio  
( 95% CI) 
Sex                                         Female  
                                                  Male 
965 
2548 
26 
83 
 
0.364 
1 
1.317 (0.726, 2.391) 
Age                                          <45Yr 
                                                 ≥45        
1846 
1667 
34 
75 
 
< 0.001 
1 
2.345 (1.557, 3.533) 
Category                                        I 1784 61  1.189 (0.760, 1.859) 
                                                      II 397 17  0.766 (0.390, 1.507) 
                                                      III 1332 31  1 
Education                              Literate 
                                             Illiterate 
2001 
1512 
48 
61 
 
0.215 
1 
1.278 (0.867, 1.883) 
Occupation                       Employed     
                                      Unemployed 
2665 
848 
72 
37 
 
0.124 
1 
1.375 (0.917, 2.064) 
Previous history of treatment       No     
                                                     Yes 
2492 
1021 
64 
45 
 
< 0.05 
1 
1.615 (1.102, 2.368) 
Smoking                                       No 
                                                    Yes 
2060 
1453 
57 
52 
 
0.239 
1 
0.733 (0.437, 1.229) 
Alcoholism                                   No 
                                                     Yes  
2434 
1079 
59 
50 
 
< 0.005 
1 
2.015 (1.357, 2.992) 
Type of DOT providers Government 1388 50 0.379 1.309 (0.718, 2.384) 
Community 1582 45 0.973 0.990 (0.542, 1.807) 
Friends, relatives, sel f and others 543 14  1 
Supervision under IP             Always 
                                                 Never 
2619 
894 
78 
31 
 
0.468 
1 
1.168 (0.768, 1.778) 
Body weight  at initial stage of 
treatment                                < 35 kg 
                                               ≥  35 
 
488 
3025 
 
34 
75 
 
< 0.001 
 
3.709 (2.434,5.652) 
1 
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officer having made the diagnosis (specialist internal
medicine).  An earlier report from South India4
showed that 39 (6%) of 676 TB patients died during
treatment period and higher death rates were
independently associated with weight <35 kgs and
history of previous treatment.  The study
recommended that possible role of nutritional
interventions should be explored among underweight
patients to reduce mortality.  A Russian study8
reported 183 (9.6%) deaths occurred among 1916
TB patients and older age, previous treatment for
TB, multi-drug resistance TB and alcoholism were
risk factors for death during treatment period.
In the present study, the survival
probability was found to be similar in all patients
irrespective of categorization.  Age, initial body
weight, previous history of treatment and
alcoholism were risk factors for higher death
rate.  Necessary actions need to be initiated in
the programme to improve body weight and
abstain from alcoholism.  The mortality rate was
slightly lower compared to that found in other
studies.  The study population consists of patients
registered during 1999-2004, so the average
morality would have come down due to patients
treated under DOTs over the period of time.  The
analysis was restricted to study population during
the treatment period, so this could be reason
for finding similar survival probabilities
irrespective of categorization.  The deaths
reported in this study are those who expired during
the treatment period and all the deaths might not
be due to TB.  In this study other risk factors for
deaths,  not due to TB, could not be identified.
This warrants for a larger study involving patients
died due to TB only by evaluation of proper
document like death certificate.
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